Updating Formularies: Considerations for Dry Eye Disease

Professionals highlight considerations for the addition of cost-effective, statistically significant therapies to payer formularies.

Related Keywords

Ryan Haumschild ,Alexander Kabiri , ,Stakeholder Summit ,Managed Care ,Economic Burden ,Direct Costs ,Indirect Costs ,Healthcare Systems ,Dry Eye ,Glaucoma ,Microinvasive Glaucoma Surgery ,Migs ,Scarred Vision ,Scarred Corneas ,Hypertension ,Diabetes ,Cholesterol ,Diabetic Retinopathy ,Neurotrophic Keratitis ,